You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂氏國際控股(01529.HK)擬90萬元收購亳州樂老號醫藥100%股權
格隆匯 07-08 21:39

格隆匯7月8日丨樂氏國際控股(01529.HK)公吿,於2025年7月8日,集團透過公司的間接全資附屬公司訂立股權轉讓協議,以收購亳州樂老號醫藥有限公司("目標公司")的100%股權,總代價為人民幣90萬元,有關代價乃經訂約方公平磋商後釐定。董事會預期是次收購短期內不會對集團的財務狀況或營運有任何重大不利影響。於完成後,目標公司將成為公司間接全資附屬公司,其財務業績將會於集團的綜合財務報表綜合入賬。

目標公司持有《藥品經營許可證》,其主要從事藥品的批發與分銷、第一類及第二類醫療儀器的銷售以及醫護人員防護醫療用品的批發等相關業務。作為製藥與最終用户消費的重要一環,目標公司經營的藥品分銷業務在保障公眾健康方面擔當重要角色。董事會認為,是次收購標誌着本集團在中醫藥領域的戰略發展邁出了重大一步,使集團的物流實力延伸至醫藥物流領域,將上游的中藥製造與下游的零售藥店及醫院連接起來。此次收購展示集團在中醫藥領域發展大計中的重要佈局。

集團計劃在目標公司現有業務的基礎上,提升管理效率,整合資源。集團的目標是成為全面的供應鏈服務供應商,拓展業務至基本分銷以外範疇,為產業鏈提供金融、數據及管理解決方案等增值服務。集團亦計劃應用數字技術以降低營運成本,並利用人工智能提高決策的準確性。通過上述措施,集團力求將其物流實力轉型為數據實力、服務實力及財務實力。此外,集團計劃以目標公司為切入點,進一步開拓產業鏈上下游商機,從而擴大其價值創造範圍。

基於上文所述,董事會認為收購目標公司符合公司及其股東的整體利益,並與集團的長期戰略目標一致。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account